1 Exogenous hormone therapy in patients seeking GAS is typical, 2 and there is an increasing trend toward continuation of hormones through the TGD patient’s perioperative course. 1 Wound healing problems are a major cause of morbidity in TGD patients who undergo GAS, such as fistula and stricture formation after phalloplasty.
← all excerpts
A Novel Mouse Model for Investigating the Effects of Gender-affirming Hormone Therapy on Surgical Healing.
1
—
—